Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.15
HRT's Cash to Debt is ranked lower than
56% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 4.48 vs. HRT: 0.15 )
HRT' s 10-Year Cash to Debt Range
Min: 0.03   Max: No Debt
Current: 0.15

Equity to Asset 0.40
HRT's Equity to Asset is ranked lower than
51% of the 367 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. HRT: 0.40 )
HRT' s 10-Year Equity to Asset Range
Min: 0.39   Max: 0.96
Current: 0.4

0.39
0.96
F-Score: 5
Z-Score: 2.30
M-Score: -3.67
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -4.48
HRT's Operating margin (%) is ranked higher than
58% of the 372 Companies
in the Global Medical Devices industry.

( Industry Median: 6.25 vs. HRT: -4.48 )
HRT' s 10-Year Operating margin (%) Range
Min: -15.6   Max: 21.71
Current: -4.48

-15.6
21.71
Net-margin (%) -16.58
HRT's Net-margin (%) is ranked higher than
56% of the 372 Companies
in the Global Medical Devices industry.

( Industry Median: 4.71 vs. HRT: -16.58 )
HRT' s 10-Year Net-margin (%) Range
Min: -29.73   Max: 16.4
Current: -16.58

-29.73
16.4
ROE (%) -55.74
HRT's ROE (%) is ranked lower than
52% of the 368 Companies
in the Global Medical Devices industry.

( Industry Median: 5.93 vs. HRT: -55.74 )
HRT' s 10-Year ROE (%) Range
Min: -63.3   Max: 15.35
Current: -55.74

-63.3
15.35
ROA (%) -21.64
HRT's ROA (%) is ranked higher than
54% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 3.43 vs. HRT: -21.64 )
HRT' s 10-Year ROA (%) Range
Min: -36.19   Max: 13.85
Current: -21.64

-36.19
13.85
ROC (Joel Greenblatt) (%) -9.44
HRT's ROC (Joel Greenblatt) (%) is ranked higher than
61% of the 381 Companies
in the Global Medical Devices industry.

( Industry Median: 13.35 vs. HRT: -9.44 )
HRT' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -38.73   Max: 36.28
Current: -9.44

-38.73
36.28
Revenue Growth (%) -2.10
HRT's Revenue Growth (%) is ranked higher than
60% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. HRT: -2.10 )
HRT' s 10-Year Revenue Growth (%) Range
Min: -25.3   Max: 34.6
Current: -2.1

-25.3
34.6
EBITDA Growth (%) -35.30
HRT's EBITDA Growth (%) is ranked higher than
55% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: -3.60 vs. HRT: -35.30 )
HRT' s 10-Year EBITDA Growth (%) Range
Min: -35.3   Max: 39.9
Current: -35.3

-35.3
39.9
» HRT's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

HRT Guru Trades in Q2 2013

Jim Simons 56,100 sh (-0.36%)
» More
Q3 2013

HRT Guru Trades in Q3 2013

Jim Simons 56,100 sh (unchged)
» More
Q4 2013

HRT Guru Trades in Q4 2013

Jim Simons 56,900 sh (+1.43%)
» More
Q1 2014

HRT Guru Trades in Q1 2014

Jim Simons 59,600 sh (+4.75%)
» More
» Details

Insider Trades

Latest Guru Trades with HRT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.80
HRT's P/B is ranked higher than
74% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 3.46 vs. HRT: 2.80 )
HRT' s 10-Year P/B Range
Min: 0.26   Max: 12.47
Current: 2.8

0.26
12.47
P/S 0.85
HRT's P/S is ranked higher than
92% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 3.30 vs. HRT: 0.85 )
HRT' s 10-Year P/S Range
Min: 0.2   Max: 14.62
Current: 0.85

0.2
14.62
EV-to-EBIT -40.70
HRT's EV-to-EBIT is ranked higher than
65% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 44.56 vs. HRT: -40.70 )
HRT' s 10-Year EV-to-EBIT Range
Min: 4   Max: 69.2
Current: -40.7

4
69.2
Current Ratio 1.73
HRT's Current Ratio is ranked higher than
56% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. HRT: 1.73 )
HRT' s 10-Year Current Ratio Range
Min: 1.04   Max: 10.41
Current: 1.73

1.04
10.41
Quick Ratio 1.17
HRT's Quick Ratio is ranked higher than
55% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 2.16 vs. HRT: 1.17 )
HRT' s 10-Year Quick Ratio Range
Min: 0.63   Max: 8.09
Current: 1.17

0.63
8.09

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 2.90
HRT's Price/Tangible Book is ranked higher than
82% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 5.99 vs. HRT: 2.90 )
HRT' s 10-Year Price/Tangible Book Range
Min: 0.38   Max: 10.73
Current: 2.9

0.38
10.73
Price/DCF (Projected) 170.00
HRT's Price/DCF (Projected) is ranked higher than
79% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. HRT: 170.00 )
HRT' s 10-Year Price/DCF (Projected) Range
Min: 0.26   Max: 129
Current: 170

0.26
129
Price/Median PS Value 1.20
HRT's Price/Median PS Value is ranked higher than
71% of the 413 Companies
in the Global Medical Devices industry.

( Industry Median: 1.20 vs. HRT: 1.20 )
HRT' s 10-Year Price/Median PS Value Range
Min: 0.34   Max: 15.04
Current: 1.2

0.34
15.04
Forward Rate of Return (Yacktman) -2.39
HRT's Forward Rate of Return (Yacktman) is ranked higher than
68% of the 306 Companies
in the Global Medical Devices industry.

( Industry Median: 0.97 vs. HRT: -2.39 )
HRT' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -12.8   Max: 41.9
Current: -2.39

-12.8
41.9

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Arrhythmia Research Technology was incorporated under the laws of the State of Louisiana in 1981 and reincorporated under the laws of the State of Delaware in 1987. It completed an initial public offering in 1988. The Company through its wholly-owned subsidiary is a manufacturer specializing in plastic molding, precision metal and plastics machining and precious metal coating. It is also engaged in the development and licensing of signal averaged electrocardiography (SAECG) software, through its Predictor brand. The Company's technologies used in analyzing high resolution heart signals. Its Predictor software is used in research and clinical environments to diagnose the risk of certain heart arrhythmias. The Company invests in research and development, product support and sales efforts. The Company sells its services to its customers to provide product life cycle support to their product manufacturing needs. It provides complex value added US based manufacturing capabilities in injection molding, machining and plating/coating, mold making, maintenance and repair. The Company's operations are subject to government regulations which establish compliance standards and result in costs to comply in order to participate in certain markets.
» More Articles for HRT

Headlines

Articles On GuruFocus.com
Longleaf Partners Believe HRT Could Be Their Most Exciting Investment Ever Jun 08 2011 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Nov 10 2010 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Aug 16 2010 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) May 04 2010 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Oct 30 2009 
Arrhythmia Research Technology Inc (HRT) CFO David A Garrison buys 5,000 Shares Sep 17 2009 
Weekly CFO Buys Highlight: Arrhythmia Research Technology, Ultra Clean Holdings, Pixelworks, Hospira Aug 16 2009 
Arrhythmia Research Technology Inc (HRT) CFO David A Garrison buys 5,000 Shares Aug 12 2009 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) Aug 04 2009 
Arrhythmia Research Technology Inc Reports Operating Results (10-Q) May 11 2009 

More From Other Websites
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive... Jul 01 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Submission of Matters to a Vote of... May 27 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Financials May 20 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 10-Q, Quarterly Report May 09 2014
Arrhythmia Research Technology, Inc. Reports Earnings Per Share of $0.09 on 6.9% Increase in First... May 09 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Financials Mar 27 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial... Mar 21 2014
Arrhythmia Research Technology, Inc. Announces Fourth Quarter and 2013 Year End Results Mar 21 2014
Needing Smarter, More Cost-Effective Production, Medical OEMs Turn to Contract Manufacturing Mar 11 2014
Arrhythmia Research Technology, Inc. Announces Supply Agreement With Blue Belt Technologies, Inc. Feb 19 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Regulation FD Disclosure Feb 14 2014
Arrhythmia Research Technology, Inc. Announces Date of Annual Meeting of Shareholders Feb 14 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Change in Directors or Principal... Jan 14 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K/A, Submission of Matters to a Vote of... Jan 10 2014
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Entry into a Material Definitive... Dec 23 2013
Arrhythmia Research Technology, Inc. Announces Closing of Private Placement Dec 23 2013
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial... Nov 19 2013
Arrhythmia Research Technology, Inc. Announces Third Quarter 2013 Results Nov 19 2013
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Changes in Registrant's Certifying... Oct 18 2013
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ Files SEC form 8-K, Results of Operations and Financial... Oct 08 2013

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide